Premature circuit clotting is a problem during continuous renal replacement therapy. We describe an algorithm for individualised anticoagulation with unfractionated heparin based on the patient's risk of bleeding and previous circuit life. The algorithm allows eff ective and safe nurse-led anticoagulation during continuous renal replacement therapy.
Introduction
Continuous renal replacement therapy (CRRT) has become an established treatment for patients with acute kidney injury in the intensive care unit (ICU). Premature circuit clotting is a common problem, leading to reduced circuit life, to reduced clearance and also to increased blood loss, work load and cost of therapy [1] . Th ere are diff erent ways of maintaining the circuit patent [2] . An international questionnaire showed that in the UK more than 98% of ICUs surveyed used unfractionated heparin [3] . Th e major advantages of unfractionated heparin are the low costs, familiarity, ease of administration and reversibility with protamine. CRRT is predominantly nurse-led [4] . After a decision is made to start CRRT, nurses usually prepare and manage the technique.
Unfractionated heparin is the fi rst-line anticoagulant in our unit. In order to enable the nursing staff to manage CRRT eff ectively and safely, we aimed to have clear guidelines in place, including an algorithm for the use of heparin.
Methods
We contacted seven large ICUs in the UK and three units outside the UK. None of the ICUs contacted had a guideline for the use of unfractionated heparin during CRRT. We therefore designed an algorithm based on data from the literature and our own clinical experience (Figure 1) .
Results
Th e principles of the algorithm (Figure 1 ) are as follows. First, unfractionated heparin is administered via the circuit. Second, heparin is administered into the circuit priming solution before the blood is in contact with plastic surfaces (10,000 iu heparin/1,000 ml of 0.9% NaCl). Th ird, the dose of heparin is based on the patient's body weight. Fourth, the starting dose of heparin is individualised depending on the risk of bleeding and the previous circuit life -subsequent doses can be adjusted by the nursing staff according to the algorithm without the need for a medical review. Fifth, there is no target activated partial thromboplastin time ratio but this ratio is kept ≤2 to prevent over-anticoagulation. Sixth, regular attention is paid to nonpharmacological methods to maintain circuit patency (that is, change of vascular access, blood fl ow, predilution/postdilution ratio).
A recent audit covering the period May 2008 to May 2009 confi rmed a mean circuit life of 19.8 hours using unfractionated heparin without any untoward incidents.
Copies of our algorithm have already been requested by several ICUs in the UK. Th e aim of the present paper is therefore to share our practice more widely.
Conclusion
Our heparin algorithm allows nurse-led eff ective and safe anticoagulation with unfractionated heparin during CRRT.
Abbreviations CRRT, continuous renal replacement therapy; ICU, intensive care unit.
